Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

Medicare-eligible patients with advanced cancers will have access to genomic tests under a national coverage determination CMS finalized March 16. The determination covers next-generation sequencing ...

Providing patient-centered education and navigation support significantly increases consent rates for genomic testing, making ...

The U.S. Food and Drug Administration (FDA) has approved Guardant360 CDx as a companion diagnostic to identify patients with ...

In 2023, Jill Martin took a test that changed her life. She underwent genetic testing for breast cancer and learned she had a BRCA2 mutation, which increases one’s risk of developing breast and other ...

REVEAL GENOMICS, S.L. is a Barcelona-based biotechnology company that discovers, develops, and markets innovative diagnostic ...

Genetic tests for cancer on NHS to help families detect ‘Jolie’ gene - Health secretary Wes Streeting has backed the plans ...

A review of the distribution of risk estimates from three commonly used genomic assays for breast cancer found that Black women were more likely to have aggressive tumor phenotypes, which contributed ...

A nationwide Australian pilot screened more than 10,000 adults aged 18–40 years for high-risk genetic variants linked to ...

NHS England will collect patient information on 100 genes linked to an increased risk of cancer, in a bid to identify those ...

FDA approves Guardant Health's blood test to help identify metastatic colorectal cancer patients eligible for targeted ...